Biobot Surgical

About Biobot Surgical

Biobot Surgical develops the Mona Lisa robotic system for targeted prostate biopsies & soft tissue ablation, pioneering robotic transperineal procedures. They differentiate through 1.0mm robotic accuracy & have completed over 25,000 procedures globally with 50+ units installed. Regulatory clearances include FDA, CE, & HSA, and they’ve expanded to markets in the US, China, Australia, & Europe. Recent developments include CE certification for the Mona Lisa 2.0 [Tx] system.

Key Products & Services

Mona Lisa, Mona Lisa 2.0 [Tx], Mona Lisa [Dx]

Industry Sectors